Advanced Pharmaceutical Manufacturing Training Curriculum Development

The contract seeks the design and development of a scientifically rigorous training curriculum focused on advanced pharmaceutical manufacturing techniques, specifically continuous manufacturing, additive manufacturing, and modular pharmaceutical systems. The deliverables include comprehensive syllabi, real-world case studies, and detailed regulatory frameworks aligned with current industry and regulatory standards. The curriculum must be structured to ensure deep technical understanding and practical application, targeting professionals in pharmaceutical production and oversight. The work is expected to meet high academic and regulatory integrity benchmarks to support workforce development in modern drug manufacturing. This subcontract is issued by the FDA Center for Drug Evaluation and Research under the U.S. Department of Health and Human Services, with performance centered in Silver Spring. The opportunity was posted on July 23, 2026, and responses are due by August 4, 2026. The North American Industry Classification System code is 611430, indicating it falls under other scientific and technical consulting services. There is no set-aside designation specified, and the contract does not include a designated point of contact. Interested parties must submit proposals through the official SAM.gov portal before the deadline to be considered for award.